Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 124, Issue 1, Pages 263-267Publisher
ELSEVIER SCIENCE INC
DOI: 10.1111/j.0022-202X.2004.23573.x
Keywords
basal cell carcinoma; cyclosporine A; hedgehog; organ transplantation; patched
Categories
Funding
- NCI NIH HHS [CA81888] Funding Source: Medline
- NIAMS NIH HHS [AR050440] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [U19CA081888] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The development of extensive and severe non-melanoma skin cancer is an extremely common complication of organ transplantation and is assumed to be caused by long-term treatment with anti-rejection drugs (ARD). Despite this florid clinical problem, ARD treatments have been reported to affect experimental murine skin carcinogenesis only weakly. We report here that treatment of cesium-137-irradiated Ptch1+/- mice with immunosuppressive doses of cyclosporine A plus prednisolone for 4-1/2 mo increased basal cell carcinoma burden by 2.5-fold. Thus, these mice provide a good model for study of the effects of long-term administration of ARD on at least one type of non-melanoma skin cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available